The exercise period for warrants series TO 13 ("TO 13") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") ended on 15 September 2025. The preliminary outcome indicates that a total ...
The exercise period for warrants series TO 13 ("TO 13") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") (the "Warrant Programme"), issued in connection with the Company's rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback